
Kelly Benning
“What we’re building at Suvi Health is different because it doesn’t just support the care team, it activates the patient and the people who love them. That’s where the real opportunity to transform care lives.”LinkedIn
Read Bio
Kelly Benning is CEO and co-founder of Suvi Health, where she leads the company’s mission to address the hospital capacity crisis using ambient AI to activate patients and caregivers, reduce length of stay, and ease the burden on care teams. She brings decades of experience building and scaling high-growth digital health companies to the role, with a track record of turning bold ideas into market-defining outcomes.
Kelly specializes in taking breakthrough healthcare technologies from concept to commercialization, guiding organizations through FDA clearance, fundraising, strategic partnerships, and rapid scale. She is known for building high-performing executive teams, creating clarity in complex environments, and driving measurable growth through disciplined execution.
Before Suvi Health, Kelly served as President of LiveMetric, where she led the company from clinical development through FDA clearance and secured partnerships with major payers and large employer plans, generating significant pre-FDA revenue. She also built research collaborations with Mayo Clinic, Columbia, and the University of Chicago to advance clinical validation. Earlier, she served as Vice President of Watson Health AI at IBM, where she drove exponential growth in the opportunity funnel and helped earn the Best in KLAS award.
Kelly also serves on the board of Prime Health, where she contributes deep expertise in digital health strategy, market development, and commercialization.
She holds a Bachelor’s degree in Kinesiology from the University of Colorado and resides in Denver, CO.
